Omada is a digital care solution that delivers integrated, virtual care across chronic conditions, a top clinical need for employers and health plans.
Omada is leading the field of digital therapeutics by creating innovative, scalable, and cost-effective online behavior change programs that address the growing epidemic of chronic disease.
Omada Health was founded in 2011 by Sean Duffy and Adrian James. The company is headquartered in San Francisco, California.
Omada's online programs combine world-class science, technology, and design to inspire and enable people everywhere to live free of chronic disease. The company has pioneered digital behavioral medicine: a new approach to tackling the growing epidemic of type 2 diabetes, heart disease, and obesity.
Omada delivers personalized interventions for diabetes, diabetes prevention, hypertension, and musculoskeletal issues. All programs include integrated behavioral health support.
Omada currently serves 1,700+ customers and 550,000 members. The company now has access to over 18 million covered lives across their employer and health plan channels, with more than 3.5 million covered lives added through new deals in 2021.
Omada is backed by Wellington Management, Fidelity Management & Research Company, Andreessen Horowitz, KP Ventures, Perceptive Advisors, USVP, Sanofi-Genzyme BioVentures, aMoon, and others. The company raised $192M in Series E round on Feb 23, 2022. This brings Omada's total funding to $448.5M to date. The latest round valued the company at over $1B post-money.